Litigation Details for Merz Pharmaceuticals, LLC v. Aurobindo Pharma Ltd. (D. Del. 2020)
✉ Email this page to a colleague
Merz Pharmaceuticals, LLC v. Aurobindo Pharma Ltd. (D. Del. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-12-23 |
| Court | District Court, D. Delaware | Date Terminated | 2021-06-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | Jennifer L. Hall |
| Patents | 7,638,552; 7,816,396 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Merz Pharmaceuticals, LLC v. Aurobindo Pharma Ltd.
Details for Merz Pharmaceuticals, LLC v. Aurobindo Pharma Ltd. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-12-23 | External link to document | |||
| 2020-12-22 | 24 | Notice of Service | Standard for Litigation Involving U.S. Patent Nos. 7,638,552 and 7,816,396 filed by Merz North America… 2020 3 June 2021 1:20-cv-01760 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-12-22 | 28 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552; 7,816,396. (Attachments… 2020 3 June 2021 1:20-cv-01760 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
